SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nabiha Faisal, Khalid Mumtaz, Max Marquez, Eberhard L. Renner, Leslie B. Lilly, High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation, Hepatology International, 2015, 9, 1, 76

    CrossRef

  2. 2
    Ching-Chih Hu, Chih-Lang Lin, Liang-Che Chang, Cheng-Hung Chien, Li-Wei Chen, Ching-Jung Liu, Rong-Nan Chien, Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study, BMC Infectious Diseases, 2015, 15, 1

    CrossRef

  3. 3
    D. Shoeb, J. Dearden, A. Weatherall, C. Bargery, S. Moreea, S. Alam, E. White, X. Vila, D. Freshwater, S. Ryder, P.R. Mills, G.J. Alexander, D. Forton, G.R. Foster, Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: Final results from the STEPS trial, Journal of Hepatology, 2014, 60, 4, 699

    CrossRef

  4. 4
    Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park, Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients, Clinical and Molecular Hepatology, 2013, 19, 2, 148

    CrossRef

  5. You have free access to this content5
    Guidelines for the Management of Hepatitis C Virus Infection, Hepatology Research, 2013, 43, 1
  6. 6
    Susanne Beckebaum, Iyad Kabar, Vito R. Cicinnati, Hepatitis B and C in liver transplantation: new strategies to combat the enemies, Reviews in Medical Virology, 2013, 23, 3
  7. 7
    Tatsuya Minami, Takahiro Kishikawa, Masaya Sato, Ryosuke Tateishi, Haruhiko Yoshida, Kazuhiko Koike, Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C, Journal of Gastroenterology, 2013, 48, 2, 254

    CrossRef

  8. 8
    Humberto C. Gonzalez, Syed Mohammed Jafri, Stuart C Gordon, Role of Liver Biopsy in the Era of Direct-Acting Antivirals, Current Gastroenterology Reports, 2013, 15, 2

    CrossRef

  9. You have free access to this content9
    Doris B. Strader, Leonard B. Seeff, A brief history of the treatment of viral hepatitis C, Clinical Liver Disease, 2012, 1, 1
  10. 10
    Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, Valérie Oules, Isabelle Portal, Souad Benali, Xavier Adhoute, Paul Castellani, Future treatment of patients with HCV cirrhosis, Liver International, 2012, 32,
  11. 11
    Anthony D. Martinez, Robert G. Gish, HCV In At Risk Populations: Who Can be Treated and How?, Current Hepatitis Reports, 2012, 11, 1, 1

    CrossRef

  12. You have free access to this content12
    Syed-Mohammed R. Jafri, Stuart C. Gordon, Is there still a role for liver biopsy in managing hepatitis C virus infections?, Clinical Liver Disease, 2012, 1, 2
  13. 13
    K. Muller, A. Rodgers, R. Wundke, V. Waddell, R. Altus, D. L. Gordon, A. Wigg, Single centre experience with pegylated interferon and ribavirin for hepatitis C: looking back before moving forward, Internal Medicine Journal, 2012, 42, 7
  14. 14
    Yasuhiro Asahina, Namiki Izumi, Makoto Oketani, Hiromitsu Kumada, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu, Hiroshi Yotsuyanagi, Treatment Guidelines of Hepatitis C, Kanzo, 2012, 53, 6, 355

    CrossRef

  15. 15
    Roberta D’Ambrosio, Alessio Aghemo, Treatment of Patients With HCV Related Cirrhosis: Many Rewards With Very Few Risks, Hepatitis Monthly, 2012, 12, 6, 361

    CrossRef

  16. 16
    Su Rin Shin, Seung Woon Paik, Geum-Youn Gwak, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Byung Chul Yoo, Antiviral Therapy in Patients after Treatment for Hepatitis C-Related Hepatocellular Carcinoma, Gut and Liver, 2011, 5, 1, 77

    CrossRef

  17. 17
    Scott A. Fink, Ira M. Jacobson, Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 5, 285

    CrossRef

  18. 18
    Jee-Fu Huang, Ming-Lung Yu, Chung-Feng Huang, Chang-Fu Chiu, Chia-Yen Dai, Ching-I. Huang, Ming-Lun Yeh, Jeng-Fu Yang, Ming-Yen Hsieh, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Wan-Long Chuang, The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial, Journal of Hepatology, 2011, 54, 2, 219

    CrossRef

  19. 19
    Ashwani K. Singal, Amanpal Singh, Sathya Jaganmohan, Praveen Guturu, Rajasekhara Mummadi, Yong–Fang Kuo, Gagan K. Sood, Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis, Clinical Gastroenterology and Hepatology, 2010, 8, 2, 192

    CrossRef

  20. 20
    Andreas Maieron, Sigrid Metz-Gercek, Franz Hackl, Alexander Ziachehabi, Harri Fuchsteiner, Christoph Luger, Helmut Mittermayer, Rainer Schöfl, Antiviral treatment of chronic hepatitis C in clinical routine, Wiener klinische Wochenschrift, 2010, 122, 7-8, 237

    CrossRef

  21. 21
    Mazen Noureddin, Marc G Ghany, Editorial: Treatment of Patients With HCV-Related Cirrhosis With Peginterferon and Ribavirin: Swinging the Pendulum Toward Treatment, The American Journal of Gastroenterology, 2010, 105, 10, 2174

    CrossRef

  22. 22
    Diane M. Settles, Rakesh Vinayek, Hepatitis C and End-stage Liver Disease, Current Hepatitis Reports, 2010, 9, 4, 243

    CrossRef

  23. 23
    Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi, Masatoshi Kudo, Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009), Hepatology Research, 2010, 40, 4
  24. 24
    Hatef Massoumi, Hussein Elsiesy, Viktoriya Khaitova, Brent Peterson, Edward Norkus, Priya Grewal, Lawrence Liu, Charissa Chang, Nancy Bach, Thomas D. Schiano, An Escalating Dose Regimen of Pegylated Interferon and Ribavirin in HCV Cirrhotic Patients Referred for Liver Transplant, Transplantation, 2009, 88, 5, 729

    CrossRef

  25. 25
    Nazia Selzner, Eberhard L. Renner, Markus Selzner, Oyedele Adeyi, Arash Kashfi, George Therapondos, Nigel Girgrah, Chaturika Herath, Gary A. Levy, Leslie Lilly, Antiviral Treatment of Recurrent Hepatitis C After Liver Transplantation: Predictors of Response and Long-Term Outcome, Transplantation, 2009, 88, 10, 1214

    CrossRef

  26. You have free access to this content26
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
  27. 27
    Shuhei Nishiguchi, Namiki Izumi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshito Ito, Yasuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi, Masatoshi Kudo, JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis C, Kanzo, 2009, 50, 11, 665

    CrossRef

  28. 28
    E. G. Giannini, M. Basso, V. Savarino, A. Picciotto, Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension, Journal of Internal Medicine, 2009, 266, 6
  29. 29
    H.-H. Thein, Q. Yi, E. J. Heathcote, M. D. Krahn, Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort, Journal of Viral Hepatitis, 2009, 16, 11
  30. 30
    Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth Rothstein, Paul Kwo, Norman Gitlin, Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results, Hepatology, 2009, 49, 6
  31. 31
    Susan J. Keam, Risto S. Cvetković, Spotlight on Peginterferon-α-2a (40 kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection†, BioDrugs, 2009, 23, 1, 63

    CrossRef

  32. 32
    A. IACOBELLIS, M. SICILIANO, B. E. ANNICCHIARICO, M. R. VALVANO, G. A. NIRO, L. ACCADIA, N. CARUSO, G. BOMBARDIERI, A. ANDRIULLI, Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients, Alimentary Pharmacology & Therapeutics, 2009, 30, 2
  33. 33
    Hui-Hui Tan, Thomas D. Schiano, Treatment of hepatitis C in the potential liver transplant recipient, Current Hepatitis Reports, 2009, 8, 2, 81

    CrossRef

  34. You have free access to this content34
    Ryosuke TAKEMOTO, Makoto NAKAMUTA, Yoko AOYAGI, Tatsuya FUJINO, Kenichiro YASUTAKE, Kotaro KOGA, Tsuyoshi YOSHIMOTO, Toshihiko MIYAHARA, Kunitaka FUKUIZUMI, Yoshiyuki WADA, Yuko TAKAMI, Hideki SAITSU, Naohiko HARADA, Manabu NAKASHIMA, Munechika ENJOJI, Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection, Journal of Digestive Diseases, 2009, 10, 2
  35. 35
    A. Yamane, T. Nakamura, H. Suzuki, M. Ito, Y. Ohnishi, Y. Ikeda, Y. Miyakawa, Interferon- 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes, Blood, 2008, 112, 3, 542

    CrossRef

  36. 36
    Yasuhiro Miyake, Masaharu Ando, Eisuke Kaji, Tatsuya Toyokawa, Morihito Nakatsu, Mamoru Hirohata, Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia, Hepatology Research, 2008, 38, 10
  37. 37
    Susan J Keam, Risto S Cvetković, Peginterferon-α-2a (40 kD) Plus Ribavirin, Drugs, 2008, 68, 9, 1273

    CrossRef

  38. 38
    E. Xirouchakis, C. Triantos, P. Manousou, A. Sigalas, V. Calvaruso, A. Corbani, G. Leandro, D. Patch, A. Burroughs, Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies, Journal of Viral Hepatitis, 2008, 15, 10
  39. 39
    Brett E Fortune, Hugo R Rosen, James R Burton, Management of HCV Infection and Liver Transplantation,